ANDA 219071, held by Teva Pharms Inc. Prucalopride Succinate.
As of Nov 16, 2026, ANDA 219071 (Prucalopride Succinate), held by Teva Pharms Inc, was first approved by FDA on Feb 5, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 5, 2026 | Original application | Approved | None posted |
| Prucalopride SuccinateEQ 1MG BASE · tablet;oral | Prucalopride Succinate | Discontinued |
| Prucalopride SuccinateEQ 2MG BASE · tablet;oral | Prucalopride Succinate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters